These studies confirm that BRD4 is involved in the transdifferentiation of lung myofibroblasts and the progression of pulmonary fibrosis, suggesting its potential as a therapeutic target for pulmonary fibrosis. This evidence concerns the gene BRD4 and pulmonary fibrosis.